CRISPR Stock Market Value

CRSP -  USA Stock  

USD 56.34  0.15  0.27%

CRISPR Therapeutics' market value is the price at which a share of CRISPR Therapeutics stock trades on a public exchange. It measures the collective expectations of CRISPR Therapeutics AG investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of CRISPR Therapeutics AG and determine expected loss or profit from investing in CRISPR Therapeutics over a given investment horizon. Continue to CRISPR Therapeutics Hype Analysis, CRISPR Therapeutics Correlation, CRISPR Therapeutics Valuation, CRISPR Therapeutics Volatility, as well as analyze CRISPR Therapeutics Alpha and Beta and CRISPR Therapeutics Performance.
Symbol
Backtest


Is CRISPR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CRISPR Therapeutics. If investors know CRISPR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CRISPR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CRISPR Therapeutics is measured differently than its book value, which is the value of CRISPR that is recorded on the company's balance sheet. Investors also form their own opinion of CRISPR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CRISPR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CRISPR Therapeutics' market value can be influenced by many factors that don't directly affect CRISPR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CRISPR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine CRISPR Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CRISPR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CRISPR Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CRISPR Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CRISPR Therapeutics.
0.00
04/22/2022
No Change 0.00  0.0 
In 31 days
05/22/2022
0.00
If you would invest  0.00  in CRISPR Therapeutics on April 22, 2022 and sell it all today you would earn a total of 0.00 from holding CRISPR Therapeutics AG or generate 0.0% return on investment in CRISPR Therapeutics over 30 days. CRISPR Therapeutics is related to or competes with Berkeley Lights, and Brickell Biotech. CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using it...

CRISPR Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CRISPR Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CRISPR Therapeutics AG upside and downside potential and time the market with a certain degree of confidence.

CRISPR Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for CRISPR Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CRISPR Therapeutics' standard deviation. In reality, there are many statistical measures that can use CRISPR Therapeutics historical prices to predict the future CRISPR Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of CRISPR Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of CRISPR Therapeutics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
51.3456.2161.08
Details
Intrinsic
Valuation
LowReal ValueHigh
50.8482.5187.38
Details
16 Analysts
Consensus
LowTarget PriceHigh
100.00160.69220.00
Details
Earnings
Estimates (10)
LowProjected EPSHigh
4.765.005.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CRISPR Therapeutics. Your research has to be compared to or analyzed against CRISPR Therapeutics' peers to derive any actionable benefits. When done correctly, CRISPR Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in CRISPR Therapeutics.

CRISPR Therapeutics Backtested Returns

We consider CRISPR Therapeutics very steady. CRISPR Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0275, which signifies that the company had 0.0275% of return per unit of return volatility over the last 3 months. Our approach to foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for CRISPR Therapeutics AG, which you can use to evaluate the future volatility of the firm. Please confirm CRISPR Therapeutics risk adjusted performance of (0.00043203), and Mean Deviation of 3.97 to double-check if the risk estimate we provide is consistent with the expected return of 0.13%.
CRISPR Therapeutics has performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.8439, which signifies a somewhat significant risk relative to the market. Let's try to break down what CRISPR's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CRISPR Therapeutics will likely underperform. Although it is extremely important to respect CRISPR Therapeutics historical returns, it is better to be realistic regarding the information on equity current trending patterns. The approach to foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By reviewing CRISPR Therapeutics technical indicators, you can today evaluate if the expected return of 0.13% will be sustainable into the future. CRISPR Therapeutics now shows a risk of 4.83%. Please confirm CRISPR Therapeutics potential upside, and the relationship between the total risk alpha and kurtosis to decide if CRISPR Therapeutics will be following its price patterns.

Auto-correlation

    
  -0.49  

Modest reverse predictability

CRISPR Therapeutics AG has modest reverse predictability. Overlapping area represents the amount of predictability between CRISPR Therapeutics time series from 22nd of April 2022 to 7th of May 2022 and 7th of May 2022 to 22nd of May 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CRISPR Therapeutics price movement. The serial correlation of -0.49 indicates that about 49.0% of current CRISPR Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.49
Spearman Rank Test-0.67
Residual Average0.0
Price Variance23.86

CRISPR Therapeutics lagged returns against current returns

Autocorrelation, which is CRISPR Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CRISPR Therapeutics' stock expected returns. We can calculate the autocorrelation of CRISPR Therapeutics returns to help us make a trade decision. For example, suppose you find that CRISPR Therapeutics stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

CRISPR Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CRISPR Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CRISPR Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CRISPR Therapeutics stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

CRISPR Therapeutics Lagged Returns

When evaluating CRISPR Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CRISPR Therapeutics stock have on its future price. CRISPR Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CRISPR Therapeutics autocorrelation shows the relationship between CRISPR Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CRISPR Therapeutics AG.
 Regressed Prices 
Share
      Timeline 

CRISPR Therapeutics Investors Sentiment

The influence of CRISPR Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in CRISPR. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

CRISPR Therapeutics Implied Volatility

    
  93.76  
CRISPR Therapeutics' implied volatility exposes the market's sentiment of CRISPR Therapeutics AG stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if CRISPR Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that CRISPR Therapeutics stock will not fluctuate a lot when CRISPR Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CRISPR Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CRISPR Therapeutics' short interest history, or implied volatility extrapolated from CRISPR Therapeutics options trading.

Current Sentiment - CRSP

CRISPR Therapeutics Investor Sentiment

Most of Macroaxis users are currently bullish on CRISPR Therapeutics AG. What is your opinion about investing in CRISPR Therapeutics AG? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with CRISPR Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CRISPR Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will appreciate offsetting losses from the drop in the long position's value.

CRISPR Therapeutics Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to CRISPR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CRISPR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CRISPR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CRISPR Therapeutics AG to buy it.
The correlation of CRISPR Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CRISPR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CRISPR Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CRISPR Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to CRISPR Therapeutics Hype Analysis, CRISPR Therapeutics Correlation, CRISPR Therapeutics Valuation, CRISPR Therapeutics Volatility, as well as analyze CRISPR Therapeutics Alpha and Beta and CRISPR Therapeutics Performance. Note that the CRISPR Therapeutics information on this page should be used as a complementary analysis to other CRISPR Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for CRISPR Stock analysis

When running CRISPR Therapeutics price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
CRISPR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CRISPR Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CRISPR Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...